BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 27039772)

  • 1. Outcomes of Metastatic Gestational Trophoblastic Neoplasia: Fourteen Year Experience from a Northern Thailand Tertiary Care Center.
    Suprasert P; Siriaree S; Manopunya M
    Asian Pac J Cancer Prev; 2016; 17(3):1357-62. PubMed ID: 27039772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of Non-Metastatic Gestational Trophoblastic Neoplasia: Twelve Year Experience from a Northern Thailand Tertiary Care Center.
    Suprasert P; Manopunya M
    Asian Pac J Cancer Prev; 2015; 16(14):5913-6. PubMed ID: 26320472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical epidemiology and management of gestational trophoblastic neoplasia in Hungary in the past 34 years.
    Fülöp V; Szigetvári I; Szepesi J; Végh G; Singh M; Berkowitz RS
    J Reprod Med; 2012; 57(7-8):310-8. PubMed ID: 22838247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gestational trophoblastic neoplasia: treatment outcomes from a single institutional experience.
    Al-Husaini H; Soudy H; Darwish A; Ahmed M; Eltigani A; Edesa W; Elhassan T; Omar A; Elghamry W; Al-Hashem H; Al-Hayli S; Madkhali I; Ahmad S; Al-Badawi IA
    Clin Transl Oncol; 2015 May; 17(5):409-15. PubMed ID: 25398721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-risk metastatic gestational trophoblastic neoplasia. Primary management with EMA-CO (etoposide, methotrexate, actinomycin D, cyclophosphamide and vincristine) chemotherapy.
    Cagayan MS
    J Reprod Med; 2012; 57(5-6):231-6. PubMed ID: 22696818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of extremely high risk and resistant gestational trophoblastic neoplasia patients in King Chulalongkorn Memorial Hospital.
    Oranratanaphan S; Lertkhachonsuk R
    Asian Pac J Cancer Prev; 2014; 15(2):925-8. PubMed ID: 24568520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment Outcomes of Gestational Trophoblastic Neoplasia in King Chulalongkorn Memorial Hospital over Two Decades.
    Lertkhachonsuk R; Wairachpanich V
    J Reprod Med; 2016; 61(5-6):238-42. PubMed ID: 27424366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human Chorionic Gonadotropin (hCG) Regression Curve for Predicting Response to EMA/CO (Etoposide, Methotrexate, Actinomycin D, Cyclophosphamide and Vincristine) Regimen in Gestational Trophoblastic Neoplasia.
    Rattanaburi A; Boonyapipat S; Supasinth Y
    Asian Pac J Cancer Prev; 2015; 16(12):5037-41. PubMed ID: 26163637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gestational trophoblastic disease: a 21-year review of the clinical experience at an Argentinean public hospital.
    Bianconi MI; Otero S; Moscheni O; Alvarez L; Storino C; Jankilevich G
    J Reprod Med; 2012; 57(7-8):341-9. PubMed ID: 22838252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic metastasis in gestational trophoblastic neoplasia: patient characteristics, prognostic factors, and outcomes.
    Barber EL; Schink JC; Lurain JR
    J Reprod Med; 2014; 59(5-6):199-203. PubMed ID: 24937957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [EMA/CO regimen for chemotherapy 24 patients with ultra high-risk gestational trophoblastic neoplasia].
    Shen T; Chen LL; Qin JL; Wang XY; Cheng XD; Xie X; Lyu WG
    Zhonghua Fu Chan Ke Za Zhi; 2018 Jun; 53(6):371-376. PubMed ID: 29961278
    [No Abstract]   [Full Text] [Related]  

  • 12. Management and prognostic analysis of patients with gestational trophoblastic neoplasia (GTN) in FIGO stage IV and its special type.
    Wang K; Chen Y
    Clin Exp Metastasis; 2021 Feb; 38(1):47-59. PubMed ID: 33219408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of salvage therapy in chemo resistant or recurrent high-risk gestational trophoblastic neoplasm.
    Anantharaju AA; Pallavi VR; Bafna UD; Rathod PS; R VC; K S; Kundargi R
    Int J Gynecol Cancer; 2019 Mar; 29(3):547-553. PubMed ID: 30700567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatal cases of gestational trophoblastic neoplasia over four decades in the Netherlands: a retrospective cohort study.
    Lybol C; Centen DW; Thomas CM; ten Kate-Booij MJ; Verheijen RH; Sweep FC; Ottevanger PB; Massuger LF
    BJOG; 2012 Nov; 119(12):1465-72. PubMed ID: 22925191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapeutic evaluation of cisplatin, etoposide, and bleomycin chemotherapy regimen in high-risk gestational trophoblastic neoplasia].
    Song SQ; Zhang GN
    Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):571-6. PubMed ID: 23141175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of nonmetastatic and metastatic low-risk gestational trophoblastic neoplasia: factors associated with resistance to single-agent methotrexate chemotherapy.
    Chapman-Davis E; Hoekstra AV; Rademaker AW; Schink JC; Lurain JR
    Gynecol Oncol; 2012 Jun; 125(3):572-5. PubMed ID: 22449733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EMACO for treatment of gestational trophoblastic neoplasia: A multinational multicenter study.
    Jareemit N; Therasakvichya S; Freitas F; Paiva G; Ramírez LAC; Berkowitz RS; Horowitz NS; Maestá I; Fülöp V; Braga A; Elias KM
    Gynecol Oncol; 2023 Mar; 170():114-122. PubMed ID: 36682089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatal gestational trophoblastic neoplasia: An analysis of treatment failures at the Brewer Trophoblastic Disease Center from 1979-2012 compared to 1962-1978.
    Neubauer NL; Strohl AE; Schink JC; Lurain JR
    Gynecol Oncol; 2015 Aug; 138(2):339-42. PubMed ID: 26047591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Actinomycin D, cisplatin, and etoposide regimen is associated with almost universal cure in patients with high-risk gestational trophoblastic neoplasia.
    Even C; Pautier P; Duvillard P; Floquet A; Kerbrat P; Troalen F; Rey A; Balleyguier C; Tazi Y; Leary A; Augereau P; Morice P; Droz JP; Fizazi K; Lhommé C
    Eur J Cancer; 2014 Aug; 50(12):2082-9. PubMed ID: 24910417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results with EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) chemotherapy in gestational trophoblastic neoplasia.
    Turan T; Karacay O; Tulunay G; Boran N; Koc S; Bozok S; Kose MF
    Int J Gynecol Cancer; 2006; 16(3):1432-8. PubMed ID: 16803542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.